Parallel trade in the life sciences sector – recent developments
Browse this blog post
Related news and insights
Blog Post: 21 November 2023
Blog Post: 29 September 2023
Intellectual Property Due Diligence Considerations in the Gaming Industry
Blog Post: 22 March 2023
Please join us on Tuesday, 26 January 2021 for a webinar on the key developments in the parallel trade of pharmaceuticals in 2020. Tine Carmeliet, Nele De Backer, Francesca Miotto, Geert Glas and Nieke Vanavermaete will talk you through recent decisions and developments in the field of parallel trade, review the impact of both Brexit and the COVID-19 pandemic on parallel trade and discuss the EU's recently announced pharmaceutical strategy, including the following topics:
- How to protect and enforce your trademarks against parallel traders and key considerations in view of the BMS conditions;
- Regulatory requirements imposed on parallel traders as well as the impact of obligations imposed under falsified medicines legislation;
- Competition law considerations relevant to parallel trade, in particular those flowing from patent settlements;
- Focus on Central and Eastern Europe: lessons learnt from infringement proceedings.
Date & Time: Tuesday, 26 January 2021 | 10:30 - 11:45 (CET)
If you wish to attend, please register here: http://bit.ly/3n1MKcE.